U.S.-MEXICO BORDER DIABETES PROJECT
PROJECT OVERVIEW
The U.S.-Mexico Border Diabetes Project (USMBDP) is a five-year U.S.-Mexico collaborative project that attempts to determine the prevalence of diabetes along the U.S.-Mexico border and to develop binational diabetes prevention and control programs that respond to the needs of the border population.
The project is expected to contribute to diminish the impact of diabetes of the border population by conducting activities in two related and chronological phases:
There are a number of Collaborative Partners that are contributing to make of this project a success. Among them are:
The U.S. – Mexico Diabetes Project Headquarters are located at the u.s.-Mexico Border, Field Office of the Pan American Health Organization in El Paso Texas additional information of this project can be obtained by writing or contacting Alfonso Ruiz at 5400 Suncrest Drive Suite C-4 phone: (915) 845-5950, fax: (915)845-4361, email: decosiog@usmbha.org.
History
In October 1998, the CDC awarded the Pan American Health Organization with $50,000 through the Office of International and Refugee Health to carry out the development of a binational prevention and control program. This task was achieved through the establishment of a binational planning committee of representatives from each of the four U.S. and six Mexican Border States and federal representatives from CDC and SSA
In 1999, CDC approved and financed the Project to conduct a prevalence and risk factors study on both sides of the U.S.-Mexico border and to develop and implement binational prevention and control programs along the border. To make this effort a success the following organizations have joined the project: Pan American Health Organization, U.S.-Mexico Border Health Association, Centers for Disease Control, Secretaria de Salud de México, State Health Authorities and Diabetes Control Programs of the ten border states, Paso del Norte Health Foundation, El Paso Diabetes Association, Border Health Foundation, California Endowment, and Project Concern International
Goals
Purpose of Data Collection
Data obtained by the USMBDP will be used to influence policy and improve the health of the
U.S. and Mexico border population in many ways.
Current USMBDP into the 21st Century
The current USMBDP began in 1999 and will include a household survey along the counties
and municipalities that touch the U.S. and Mexico border. We will survey approximately
4,000 people. In addition, the data collected will support the development
border/culturally/sensitive diabetes prevention and control project on both sides of the
U.S.-Mexico border.
You, or a member of your family, may have a chance to take part in an important bionational health survey. The Pan American Health Organization has been charged with the administrative and technical responsibility to implement the project in collaboration with other partners.
All residents of U.S. – Mexico Border over 18 years of age are eligible for this survey.
Participants are selected through a complex statistical process
using the 1990 Census information. In simple terms, USMBDP divides the border into
communities. The communities are divided into neighborhoods. The neighborhoods are
selected at random. From each neighborhood, housing units are selected at random. Selected
households are approached by our interviewers who ask residents a few short questions to
determine if their household is eligible for the study. (You may have received our
introductory letter, sent to "resident" at your home address.)
If you are selected to be a participant, no other person can be substituted for you. No
one can take your place in this survey. You will be selected based on your age and your
date of birth (which come from a list of birthdays provided by an informant living in your
household).
USMBDP was born out of a border initiative with participation of the Center for Disease Control and Prevention, the Secretariat of Health of Mexico, the Pan American Health Organization and the 10 Diabetes Control Programs of the 10 U.S.-Mexico Border states ( U.S.: Arizona, California, New Mexico and Texas; Mexico: Baja California, Chihuahua, Coahuila, Nuevo Leon, Sonora and Tamaulipas). The study has been reviewed by the Internal Review Board (IRB) and the Office of Management Budget (OMB). Both have granted the project clearance under the IRB No. 2638 and OMB No. 0920-0489.
The USMBDP staff consist of professional individuals with a variety of health, research, and academic backgrounds. The local staff will consist of field supervisors, interviewers and phlebotomists, all personal is highly trained The home interviewers have a wide experience administering interviews. The staffs at headquarters include: medical doctors, PhDs, health educators.
The purpose of the Consent form is to assure the participants that all the obtained information will be kept confidentially, and no harm will occur to him/her because of the survey (Public Health Service Act (42 USC 242k) authorizes collection and Section 308(d) of that law (42 USC 242m) and the Privacy Act of 1974 (5 USC 552A) prohibits us from giving out information that identifies you or your family without your consent).
This consent form should be read allow to the participant and it should be signed by him/her. Once signed, a copy of this letter sheet should be given to him/her. This means that we cannot give out any fact about you, even if a court of law asks for it. We will keep all survey data restricted files at Headquarters.
The benefits of participating in this project are: (1) You will be tested for diabetes. If you have diabetes and do not know it you will be refered to a health care provider who can make recommendations to help you avoid problems cause by diabetes and (2) You will give important information for us to help people with diabetes in your area.
There are three main parts to this survey, the home interview, anthropometric/blood pressure measurements and blood exam (Fasting Plasma Glucose and Glicohemoglobine)
The Interview
Two
Anything you say during this interview is confidential. At the end of your interview, an appointment will be made so a phlebotomist can visit you to draw a blood sample to determine if you have diabetes and/or if you currently have diabetes how well you control your diabetes.
The anthropometric and blood pressure measurements*
Body measurements of height, weight, hip and waist dimensions are important
because of repeated demonstrations that this simple measurements are good indicators of
health risk. Blood pressure (hypertension ) is a cardiovascular risk factor frequently
associated with diabetes.
Laboratory Exams
The laboratory test will help determine the presence of high glucose in the blood and/or if you already have diabetes how well you control your diabetes. The laboratory tests to be used in this study are: (1) fasting plasma glucose (FPG) and; (2) glycohemoglobin (GHB) in whole blood.
To discuss any aspect of the survey, you can call to Dr. Rosalba Ruiz at the Field Office of the Pan American Health Organization at (915) 845-5950. If you have questions about your rights as a survey participant, call CDC/ATSDR Reports Clearance Office: 1600 Clifort Road NE,MS D-24, Atlanta, Georgia 30333.